- Corporate Officers - L
- Lewis-hall Freda C
Insider Trading History of Lewis-hall Freda C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lewis-hall Freda C since 2008.
This trader's CIK number is 1437909.
At the time of last reporting, Lewis-hall Freda C was the Officer of 1life Healthcare Inc. (stock ticker symbol ONEM).
Also see all insider trading activities at 1life Healthcare Inc.
Note that in the past
Lewis-Hall Freda C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pfizer Inc (PFE) by Lewis-hall Freda C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | PFE | 0 | $0 | 0 | $0 | 343,822 | $8,143,095 |
| 2018 | PFE | 0 | $0 | 0 | $0 | 196,502 | $4,600,069 |
| 2017 | PFE | 0 | $0 | 0 | $0 | 103,155 | $2,169,349 |
| 2016 | PFE | 0 | $0 | 0 | $0 | 110,981 | $2,097,540 |
| 2015 | PFE | 0 | $0 | 0 | $0 | 101,351 | $1,792,899 |
| 2013 | PFE | 0 | $0 | 38,461 | $1,103,830 | 0 | $0 |
Yearly summary of insider trading at Vertex Pharmaceuticals Inc / Ma (VRTX) by Lewis-hall Freda C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | VRTX | 0 | $0 | 1,250 | $36,387 | 0 | $0 |
| 2008 | VRTX | 0 | $0 | 2,500 | $69,875 | 0 | $0 |
Yearly summary of insider trading at 1life Healthcare Inc (ONEM) by Lewis-hall Freda C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ONEM | 0 | $0 | 0 | $0 | 4,534 | $0 |
Yearly summary of insider trading at Springworks Therapeutics, Inc. (SWTX) by Lewis-hall Freda C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | SWTX | 50,000 | $900,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Lewis-hall Freda C:
1. Pfizer Inc (PFE)
2. Vertex Pharmaceuticals Inc / Ma (VRTX)
3. 1life Healthcare Inc (ONEM)
4. Springworks Therapeutics, Inc. (SWTX)
Table 1. Insider trading of Pfizer Inc (PFE) by Lewis-hall Freda C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-27 | PFE | Option Ex | 81,475 | 32.23 | 2,625,939 |
| 2019-02-23 | PFE | Option Ex | 87,449 | 21.03 | 1,839,052 |
| 2019-02-23 | PFE | Option Ex | 87,449 | 21.03 | 1,839,052 |
| 2019-02-23 | PFE | Option Ex | 87,449 | 21.03 | 1,839,052 |
| 2018-02-28 | PFE | Option Ex | 104,626 | 27.37 | 2,863,613 |
| 2018-02-24 | PFE | Option Ex | 91,876 | 18.90 | 1,736,456 |
| 2017-02-23 | PFE | Option Ex | 103,155 | 21.03 | 2,169,349 |
| 2016-02-24 | PFE | Option Ex | 110,981 | 18.90 | 2,097,540 |
| 2015-02-25 | PFE | Option Ex | 101,351 | 17.69 | 1,792,899 |
| 2013-09-16 | PFE | Sale | 38,461 | 28.70 | 1,103,830 |
Table 2. Insider trading of Vertex Pharmaceuticals Inc / Ma (VRTX) by Lewis-hall Freda C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-03-19 | VRTX | Sale | 1,250 | 29.11 | 36,387 |
| 2008-12-19 | VRTX | Sale | 1,250 | 29.90 | 37,375 |
| 2008-12-10 | VRTX | Sale | 152 | 26.00 | 3,952 |
| 2008-12-11 | VRTX | Sale | 1,098 | 26.00 | 28,548 |
Table 3. Insider trading of 1life Healthcare Inc (ONEM) by Lewis-hall Freda C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-02 | ONEM | Option Ex | 4,534 | .00 | 0 |
Table 4. Insider trading of Springworks Therapeutics, Inc. (SWTX) by Lewis-hall Freda C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-09-17 | SWTX | Buy | 50,000 | 18.00 | 900,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lewis-hall Freda C
(Officer of 1life Healthcare Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.